Aptamer Group partners with biotech firm to target genetic medicines with Optimers
LONDON: Aptamer Group plc, a company that develops novel Optimer binders for the life sciences industry, has signed a deal with a biotech firm that makes genetic medicines. The deal involves using Aptamer Group’s platform to discover Optimers that can…